In vitro effect of N-acetyl-L-cysteine on glutathione and sulfhydryl levels in X-linked adrenoleukodystrophy patients
Keywords:
X- linked adrenoleukodystrophy, N-acetyl-L-cysteine, glutathione, sulfhydrylAbstract
Introduction: Recent evidence shows that oxidative stress seems to be related with the pathophysiology of X-linked adrenoleukodystrophy (X-ALD), a neurodegenerative disorder. Methods: In the present study, the in vitro effect of N-acetyl-L-cysteine (NAC) on glutathione (GSH) and sulfhydryl levels in X-ALD patients was evaluated. Results: A significant reduction of GSH and sulfhydryl content was observed in X-ALD patients compared to the control group. Furthermore, 5 mM of NAC, in vitro, led to an increase in GSH content and sulfhydryl groups in these patients. Conclusion: These data probably indicate that an adjuvant therapy with the antioxidant NAC could improve the oxidative imbalance in X-ALD patients.
Keywords: X- linked adrenoleukodystrophy; N-acetyl-L-cysteine; glutathione; sulfhydryl
Downloads
References
Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, edithors. The Metabolic and Molecular Bases of Inherited Disease, 8th ed., New York: McGraw-Hill Inc; 2001. p. 3257-3301.
Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014; 98:135-142.
Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P, Ferrer I, Pujol A. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta. 2012; 1822:1475-1488.
Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2004; 1688:26-32.
Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, et al. Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Mol Genet Metab. 2013; 109:366-370.
Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003; 60:6-20.
Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg Leonore A. N-
Acetylcysteine: a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007; 7:355-359.
Di Biase A, Benedetto R, Salvati S, Attorri L, Leonardi F, Pietraforte D. Effects of L-mono methy-arginine, N-acetyl-L-cysteine and diphenyleniodonium on free radical release in C6 glial cells enriched in hexacosanoic acid. Neurochem Res. 2005; 30(2):215-223.
Galino J, Ruiz M, Fourcade S Schlüter A, López-Erauskin J, Guilera C, et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal. 2011; 15(8): 2095-2107.
López-Erauskin J, Fourcade S, Galino J, Ruiz M, Schlüter A, Naudi A, et al. Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy. Ann Neurol. 2011; 70:84-92.
Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007; 39: 211-215.
Abt G, Vaghef H, Gebhart E, Dahlgren CV, Hellman B. The role of N acetylcysteine as a putative radioprotective agent on X-ray-induced DNA damage as evaluated by alkaline single-cell gel electrophoresis. Mutat Res. 1997; 384:55-64.
Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol Biol. 1998; 108:347-352.
Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett. 2001; 302:141-145.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265-275.
Deon M, Sitta A, Barschak AG, Coelho DM, Pigatto M, Schmitt GO, et al. Introduction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. Int J Devl Neuroscience. 2007; 25:441-444.
Rockenbach FJ, Deon M, Marchese DP, Manfredini V, Mescka C,
Ribas GS, et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. Mol Genet Metab. 2012; 106: 231-236.
Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine. Oxford: Oxford University Press; 2007.
Johnson WM, Wilson-Delfosse AL, Mieyal JJ. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients. 2012; 4:1399-1440.
Farr SA, Poon HF, Dogrukol-Ak, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003; 84:1173-1183.
Tchantchou F, Graves M, Rogers E, Ortiz D, Shea TB. N-acetyl-cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency. J Alzheimers Dis. 2005; 7:135-138.
Terrill JR, Radley-Crabb HG, Grounds MD, Arthur PG. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis. Neuromuscul Disord. 2012; 22(5):427-434.
Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Öz G. N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson’s Diseases. Clin Neuropharmacol. 2013; 36(4):103-106.
Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014; 141:150-159.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
